Merck Challenging Teva’s Generic Nasonex Bid

Drug Industry Daily
A A
Merck filed a lawsuit last week seeking to head off a bid by Teva for a generic version of the brand manufacturer’s Nasonex allergy spray.

To View This Article:

Login

Subscribe To Drug Industry Daily